Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age related macular degeneration
|
663 | 0.605 | 0.600 | 6 | 43769749 | upstream gene variant | C/G;T | snv | 0.060 | 0.833 | 6 | 2009 | 2019 | ||||||
Diabetic Retinopathy
|
213 | 0.605 | 0.600 | 6 | 43769749 | upstream gene variant | C/G;T | snv | 0.040 | 1.000 | 4 | 2011 | 2017 | ||||||
Psoriasis
|
705 | 0.605 | 0.600 | 6 | 43769749 | upstream gene variant | C/G;T | snv | 0.040 | 1.000 | 4 | 2014 | 2020 | ||||||
Carcinoma of lung
|
1204 | 0.605 | 0.600 | 6 | 43769749 | upstream gene variant | C/G;T | snv | 0.030 | 1.000 | 3 | 2014 | 2017 | ||||||
Malignant neoplasm of lung
|
1142 | 0.605 | 0.600 | 6 | 43769749 | upstream gene variant | C/G;T | snv | 0.030 | 1.000 | 3 | 2014 | 2017 | ||||||
Neoplasms
|
1644 | 0.605 | 0.600 | 6 | 43769749 | upstream gene variant | C/G;T | snv | 0.030 | 0.667 | 3 | 2013 | 2016 | ||||||
Primary malignant neoplasm of lung
|
981 | 0.605 | 0.600 | 6 | 43769749 | upstream gene variant | C/G;T | snv | 0.030 | 1.000 | 3 | 2014 | 2017 | ||||||
Colorectal Carcinoma
|
1962 | 0.605 | 0.600 | 6 | 43769749 | upstream gene variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2014 | 2017 | ||||||
Polycystic Ovary Syndrome
|
363 | 0.605 | 0.600 | 6 | 43769749 | upstream gene variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2019 | 2019 | ||||||
Adenocarcinoma
|
168 | 0.605 | 0.600 | 6 | 43769749 | upstream gene variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Adult Glioblastoma
|
98 | 0.605 | 0.600 | 6 | 43769749 | upstream gene variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Breast Carcinoma
|
2793 | 0.605 | 0.600 | 6 | 43769749 | upstream gene variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
cervical cancer
|
268 | 0.605 | 0.600 | 6 | 43769749 | upstream gene variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Cervix carcinoma
|
283 | 0.605 | 0.600 | 6 | 43769749 | upstream gene variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Childhood Glioblastoma
|
98 | 0.605 | 0.600 | 6 | 43769749 | upstream gene variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Chronic Lymphocytic Leukemia
|
291 | 0.605 | 0.600 | 6 | 43769749 | upstream gene variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Coronary heart disease
|
1178 | 0.605 | 0.600 | 6 | 43769749 | upstream gene variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Diabetic Nephropathy
|
238 | 0.605 | 0.600 | 6 | 43769749 | upstream gene variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Endometriosis
|
274 | 0.605 | 0.600 | 6 | 43769749 | upstream gene variant | C/G;T | snv | 0.010 | 1 | 2013 | 2013 | |||||||
Exudative age-related macular degeneration
|
109 | 0.605 | 0.600 | 6 | 43769749 | upstream gene variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Glioblastoma
|
281 | 0.605 | 0.600 | 6 | 43769749 | upstream gene variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Glioblastoma Multiforme
|
186 | 0.605 | 0.600 | 6 | 43769749 | upstream gene variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Glioma
|
353 | 0.605 | 0.600 | 6 | 43769749 | upstream gene variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Glycogen storage disease type II
|
269 | 0.605 | 0.600 | 6 | 43769749 | upstream gene variant | C/G;T | snv | 0.010 | 1 | 2013 | 2013 | |||||||
hypertensive nephropathy
|
8 | 0.605 | 0.600 | 6 | 43769749 | upstream gene variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2011 | 2011 |